a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose

Metabolite details

Identifier

DPTWUYFOEZBIEX-UHFFFAOYSA-N

InChI Key

DPTWUYFOEZBIEX-UHFFFAOYSA-N

IUPAC name

2-[4,5-dihydroxy-6-(hydroxymethyl)-2-(2,4,5-trihydroxyoxan-3-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Preferred name

a-L-Fucopyranosyl-(1->2)-b-D-galactopyranosyl-(1->2)-D-xylose

INN name

—

Synonym

—

ChEBI

CHEBI:173182

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Wild_type_vs_hfq
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_CF_high
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d